Nationwide Fund Advisors - TRANSCEPT PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$3,000
+50.0%
1,2370.0%0.00%
Q2 2014$2,000
-50.0%
1,2370.0%0.00%
Q1 2014$4,0000.0%1,2370.0%0.00%
Q4 2013$4,0000.0%1,2370.0%0.00%
Q3 2013$4,000
-81.0%
1,237
-82.1%
0.00%
Q2 2013$21,0006,9000.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,031,874$6,258,0006.29%
NEA Management Company, LLC 2,086,755$6,427,0000.32%
BVF INC/IL 150,000$462,0000.07%
Central Square Management LLC 19,000$59,0000.06%
ABNER HERRMAN & BROCK LLC 20,000$62,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 137,000$422,0000.01%
SHEPHERD KAPLAN KROCHUK, LLC 31,000$95,0000.01%
Spark Investment Management LLC 11,100$34,0000.01%
Waverly Advisors, LLC 2,670$8,0000.00%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 33,384$103,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders